Roszet Dosage
Generic name: ROSUVASTATIN CALCIUM 5.2mg, EZETIMIBE 10mg
Dosage form: tablet
Drug class: Antihyperlipidemic combinations
Medically reviewed by Drugs.com. Last updated on Sep 5, 2024.
Recommended Dosage and Administration Information
- Swallow ROSZET tablets whole at any time of day, with or without food. Do not crush, dissolve, or chew tablets.
- The dosage range is 5 mg/10 mg to 40 mg/10 mg once daily.
- The recommended dose of ROSZET depends on a patient’s indication for usage, LDL-C, and individual risk for cardiovascular events.
- The starting dosage for patients switching to ROSZET from co-administration of a statin and ezetimibe is based on an equivalent dose of rosuvastatin and 10 mg of ezetimibe.
- Assess LDL-C when clinically appropriate, as early as 2 weeks after initiating ROSZET, and adjust the dosage if necessary.
Recommended Dosage in Asian Patients
Initiate ROSZET at 5 mg/10 mg daily due to increased rosuvastatin plasma concentrations. Consider the risk/benefit when treating Asian patients not adequately controlled at doses up to 20 mg/10 mg once daily.
Recommended Dosage in Patients with Renal Impairment
In patients with severe renal impairment (CLcr less than 30 mL/min/1.73 m2) not on hemodialysis, the recommended starting dosage is 5 mg/10 mg once daily and should not exceed 10 mg/10 mg once daily.
There are no dosage adjustment recommendations for patients with mild and moderate renal impairment.
Dosage and Administration Modifications Due to Drug Interactions
- In patients taking a bile acid sequestrant, administer ROSZET at least 2 hours before or 4 hours after the bile acid sequestrant.
- When taking ROSZET with an aluminum and magnesium hydroxide combination antacid, administer ROSZET at least 2 hours before the antacid.
- Concomitant use of ROSZET with the following drugs requires dosage modifications of ROSZET.
Darolutamide
Do not exceed ROSZET 5 mg/10 mg once daily.
Regorafenib
Do not exceed ROSZET 10 mg/10 mg once daily.
Antiviral Medications
Concomitant use of sofosbuvir/velpatasvir/voxilaprevir and ledipasvir/sofosbuvir with ROSZET is not recommended.
In patients taking simeprevir, dasabuvir/ombitasvir/paritaprevir/ritonavir, elbasvir/grazoprevir, sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, atazanavir/ritonavir, and lopinavir/ritonavir initiate ROSZET at 5 mg/10 mg once daily. Do not exceed ROSZET 10 mg/10 mg once daily.
No dose adjustment is needed for concomitant use with fosamprenavir/ritonavir or tipranavir/ritonavir.
More about Roszet (ezetimibe / rosuvastatin)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- During pregnancy
- FDA approval history
- Drug class: antihyperlipidemic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.